Drug & intervention

Xtandi

RxCUI 1307304

Clinical trials4

Recruiting1

Related conditions5

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

4 shown

Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.NCT07717268 · 2024-05-16

Denosumab in Combination With Enzalutamide in Progressive Metastatic Castrate-resistant Prostate Cancer and Bone Metastases.NCT03869762 · 2019-01-09

Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review StudyNCT03325127 · 2017-10-30

A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.NCT03103724 · 2017-03-16

Conditions being studied

Prostatic Neoplasms, Castration-Resistant2 Bone Metastases1 Carcinoma Prostate1 Castration-resistant Prostate Cancer1 Metastatic Cancer1

Research locations

BarcelonaBarcelona, Spain1 BarcelonaCatalonia, Spain1 MadridMadrid, Spain1 MilanItaly1

Leading sponsors

Bayer1 Cancer Trials Ireland1 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.